Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 72.40 -1.24 (-1.68%) | NSE 72.66 -0.85 (-1.16%) | Trade | Add

BSE Live

Jan 08, 16:01

72.40 -1.24 (-1.68%)

Volume

AVERAGE VOLUME

5-Day

390

10-Day

2,342

30-Day

1,268

586

Prev. Close

73.64
Open Price

72.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 08, 15:47

72.66 -0.85 (-1.16%)

Volume

AVERAGE VOLUME

5-Day

2,864

10-Day

6,127

30-Day

6,941

4,074

Prev. Close

73.51
Open Price

73.00

Bid Price (Qty.)
72.66 (20)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Bal Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	303.08	326.35	304.22	279.70	246.94
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	303.08	326.35	304.22	279.70	246.94
Total Operating Revenues	303.08	339.22	304.22	281.21	250.53
Other Income	2.20	2.85	0.94	5.15	1.14
Total Revenue	305.29	342.07	305.16	286.37	251.67
EXPENSES
Cost Of Materials Consumed	149.89	181.58	179.19	163.99	135.47
Purchase Of Stock-In Trade	15.06	11.24	11.45	8.43	10.43
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-7.05	-1.06	-17.87	-4.89	5.05
Employee Benefit Expenses	62.40	60.38	55.30	47.25	41.88
Finance Costs	16.85	15.26	12.19	10.41	11.97
Depreciation And Amortisation Expenses	9.77	10.07	9.13	9.04	9.52
Other Expenses	53.23	55.56	51.03	42.96	33.25
Total Expenses	300.15	333.02	300.41	277.18	247.56
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.14	9.05	4.75	9.18	4.10
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	5.14	9.05	4.75	9.18	4.10
Tax Expenses-Continued Operations
Current Tax	0.00	3.20	2.58	4.48	0.38
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.96	0.85	0.10	-1.94	-0.99
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	-2.10	1.60	2.13	3.48	-0.61
Profit/Loss After Tax And Before ExtraOrdinary Items	7.24	7.45	2.62	5.70	4.71
Profit/Loss From Continuing Operations	7.24	7.45	2.62	5.70	4.71
Profit/Loss For The Period	7.24	7.45	2.62	5.70	4.71
Minority Interest	-0.02	-0.05	-0.05	-0.09	0.03
Consolidated Profit/Loss After MI And Associates	7.22	7.39	2.57	5.61	4.74
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	5.00	5.00	2.00	4.00	3.00
Diluted EPS (Rs.)	5.00	5.00	2.00	4.00	3.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	1.91	1.57	1.56	1.48	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00